Use the basic search or click on advanced for more search options.

Advanced Search Basic Search Advanced Search



Select publication to see the relevant sections.

Publication Date

    E.g., 2018-10-23
    E.g., 2018-10-23

Archive Search

2 results
12:00 AM, Aug 15, 2016  |  BioCentury | Finance

Serving returns

III Sorrento Therapeutics Inc. (NASDAQ:SRNE) Four biosimilar mAbs for cancer and autoimmune indications licensed from Mabtech
12:00 AM, Aug 22, 2005  |  BioCentury | Emerging Company Profile

Corporate Profile

Corporate partners: NA Employees: 24 Funds raised: £10 million ($18.6 million) Investors: Prelude Ventures; Quester; Mabtech